ReEmerge Raises $37M to Advance Brain Injury Technology
Boston, Massachusetts, U.S., September 15, 2026 ReEmerge, Inc. has emerged from stealth with an oversubscribed $37 million Series A...
neurotechnology
Advertisement
CraniUS Wins FDA 510(k) Clearance for Cranial Implant
Baltimore, Maryland, September 9, 2026 CraniUS Therapeutics has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the...
ONWARD Medical Begins EIGER Study With First ARC-IM Implant
Eindhoven, Netherlands, September 3, 2026 ONWARD Medical announced the first implant in the new EIGER clinical feasibility study, evaluating...
Aqua Medical Advances PIMA Trial for Type 2 Diabetes
PLEASANTON, Calif., August 18, 2026 Aqua Medical, Inc. announced the treatment of the first West Coast patient in its...
Resivant Medical Advances Cutiva PLUS in First Human Use
AKRON, Ohio, August 18, 2026 Resivant Medical announced the successful completion of the first patient cases using its Cutiva™...
Advertisements
Kandu Reports Positive IpsiHand BCI Stroke Trial Results
VAN NUYS, Calif., August 18, 2026 Kandu, Inc. announced the publication of results from BCI-REHAB, the first randomized controlled...
Datasea Lists NeuroVibe as FDA Class II Biofeedback Device
Beijing, China, August,11, 2026 Datasea Intelligent Technology Ltd. has announced that its variable interest entity, Shuhai Jingwei (Shenzhen) Information...
CraniUS Secures NIH Grant for Glioblastoma Therapy
BALTIMORE, June 29, 2026 CraniUS Therapeutics has received an initial $1.1 million award through the National Institutes of Health...
Orion Pharma Expands Europe Biosimilar Portfolio with Shilpa
ESPOO, Finland, June 30, 2026 Orion Pharma has announced a strategic agreement with Shilpa Biologicals Private Limited, a wholly...
Aurenar Wins FDA Breakthrough Device Status for V-Link™
ST. LOUIS, Mo., June 30, 2026 Aurenar has announced that the U.S. Food and Drug Administration (FDA) has granted...
Advertisement
